The 2021 pharmacovigilance outsourcing imperative.
Why outsource now?
Managing pharmacovigilance in-house is no longer cost effective. The pharma industry, like many others, has seen a massive transformation since the beginning of the coronavirus pandemic.
This has opened up a once in a generation opportunity to make changes that will lead to much more effective and cost-efficient pharmacovigilance.
In 2021, tapping into the PV resources the business needs, on demand, is a much more cost-effective way of doing things.
Flexible outsourcing can supplement in-house resources and take away the cost and headache of ownership.
In this eBook, we take a look at how PV outsourcing works in practice across different departments
